摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N2-(3-bromo-4-morpholin-4-ylphenyl)-5-chloro-N4-3-vinylphenylpyrimidine-2,4-diamine | 1352244-26-8

中文名称
——
中文别名
——
英文名称
N2-(3-bromo-4-morpholin-4-ylphenyl)-5-chloro-N4-3-vinylphenylpyrimidine-2,4-diamine
英文别名
——
N2-(3-bromo-4-morpholin-4-ylphenyl)-5-chloro-N4-3-vinylphenylpyrimidine-2,4-diamine化学式
CAS
1352244-26-8
化学式
C22H21BrClN5O
mdl
——
分子量
486.799
InChiKey
FCRRFVFEOHLFOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.86
  • 重原子数:
    30.0
  • 可旋转键数:
    6.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    62.31
  • 氢给体数:
    2.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles
    摘要:
    A novel set of 2,4,8,22-tetraazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles were prepared as potential anaplastic lymphoma kinase (ALK) inhibitors, designed to rigidly lock an energy-minimized bioactive conformation of the diaminopyrimidine (DAP) scaffold, a well-documented kinase platform. From 13 analogues prepared, macrocycle 2m showed the most promising in vitro ALK enzymatic (IC50 = 0.5 nM) and cellular (IC50 = 10 nM) activities. In addition, macrocycle 2m exhibited a favorable kinase selectivity preference for inhibition of ALK relative to the highly homologous insulin receptor (IR) kinase (IR/ALK ratio of 173). The inclusive in vitro biological results for this set of macrocycles validate this scaffold as a viable kinase template and further corroborate recent DAP/ALK solid state studies indicating that the inverted "U" shaped conformation of the acyclic DAPs is a preferred bioactive conformation.
    DOI:
    10.1021/jm201333e
  • 作为产物:
    参考文献:
    名称:
    [EN] MACROCYCLIC COMPOUNDS AS ALK, FAK AND JAK2 INHIBITORS
    [FR] COMPOSÉS MACROCYLCIQUES COMME INHIBITEURS D'ALK, DE FAK ET DE JAK2
    摘要:
    本发明提供了式I的化合物或其药用可接受的盐形式,其中R1、R2、R3、R4、R5、A和X如本文所定义,以及其治疗方法和用途。
    公开号:
    WO2012125603A1
点击查看最新优质反应信息